Bezafibrate
Approved
Description
Bezafibrate is a fibric acid derivative used to treat hyperlipidemia. It is sometimes used off-label in the management of carnitine palmitoyltransferase II deficiency to improve energy metabolism.
Indications & Therapeutic Use
Hyperlipidemia, Carnitine palmitoyltransferase II deficiency (off-label)
Linked Diseases:
Global Availability (3 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Bezafibrate
| Generic Name | Bezafibrate |
| Brands | 1 brand available |
| Active Ingredient | Bezafibrate |
| Drug Class | Hyperlipidemia |
| Dosage Forms | Oral tablet |
| Medical Code | C10AB02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | Approved |
| Countries | 3 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations4 Validated Nodes